Immage Biotherapeutics Net income (Q2, 2017)-44.1 K
Immage Biotherapeutics Cash, 28-Feb-201753.7 K

Immage Biotherapeutics Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

R&D expense

62.2k

General and administrative expense

3.1k11.0k98.9k

Operating expense total

3.1k11.0k161.1k

EBIT

(18.6k)

Pre tax profit

(53.9k)

Net Income

(12.0k)(18.6k)(53.9k)(216.5k)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

R&D expense

34.7k9.7k1.6m5.7k

General and administrative expense

1.1k2.2k839.0685.02.0k1.5k4.3k19.8k27.3k26.0k28.0k24.4k

Operating expense total

1.1k2.2k839.0685.02.0k1.5k4.3k19.8k62.0k35.7k1.7m30.1k

EBIT

(4.1k)(9.7k)(4.5k)

Interest expense

801.0

Pre tax profit

(22.5k)

Net Income

(3.1k)(10.6k)(2.6k)(4.1k)(9.7k)(4.5k)(22.5k)(34.0k)(69.6k)(50.9k)(1.7m)(44.1k)

Immage Biotherapeutics Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

7.2k2.3k32.7k196.7k

Accounts Receivable

269.2m

Prepaid Expenses

904.0

Current Assets

33.6k205.0k

PP&E

40.4k

Total Assets

7.2k2.3k80.2k243.1k

Accounts Payable

900.03.5k3.0k

Short-term debt

79.0

Current Liabilities

16.1k24.0k51.4k55.8k

Total Debt

79.0

Total Liabilities

55.8k

Common Stock

5.0k100.8k

Additional Paid-in Capital

10.5k386.3k343.4k

Retained Earnings

13.9k(86.4k)(302.8k)

Total Equity

(8.9k)(21.6k)28.8k187.3k

Debt to Equity Ratio

0 x

Debt to Assets Ratio

0 x

Financial Leverage

-0.8 x-0.1 x2.8 x1.3 x

Immage Biotherapeutics Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(12.0k)(18.6k)(53.9k)(216.5k)

Depreciation and Amortization

764.08.5k

Accounts Payable

150.01.7k(444.0)

Cash From Operating Activities

(11.9k)(52.4k)(215.8k)

Purchases of PP&E

(41.1k)

Cash From Investing Activities

(41.1k)

Cash From Financing Activities

14.1k123.7k379.9k

Net Change in Cash

2.2k30.3k164.0k

Quarterly

Immage Biotherapeutics Ratios

USDY, 2017

Financial Leverage

4.1 x